Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (Pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.

被引：0
|
作者：
West, H
Belt, RJ
Wakelee, HA
Bloss, LP
Taylor, L
Monberg, MJ
Ye, Z
Obasaju, CK
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] Kansas City Canc Ctr, Kansas City, MO USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：649S / 649S
页数：1
相关论文
共 50 条
  • [41] A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Agelaki, S
    Papadakis, E
    Tsiafaki, X
    Rapti, A
    Toubis, M
    Bania, E
    Kalbakis, K
    Kouroussis, C
    Androulakis, N
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S256 - S256
  • [42] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
  • [43] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
    Aerts, Joachim G.
    van Klaveren, Rob J.
    Surmont, Veerle
    Senan, Suresh
    Tan, Yoeke
    Vernhout, Rene
    van Wijhe, Gerda
    Verhoeven, Gert T.
    Hoogsteden, Henk C.
    van Meerbeeck, Jan P.
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
  • [44] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [45] SUNITINIB MALATE AS MAINTENANCE THERAPY IN PATIENTS (PTS) WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Blais, N.
    Page, R.
    Hainsworth, J.
    Soria, J.
    Laskin, J.
    Hamm, J. T.
    Selaru, P.
    Kim, S. T.
    Chao, R.
    Gervais, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [46] Front-line treatment of advanced non-small cell lung cancer with Docetaxel and Irinotecan: A multicenter phase II trial
    Ziotopoulos, P.
    Mylonaki, E.
    Boukovinas, J.
    Agelidou, M.
    Chandrinos, V.
    Zachariadis, E.
    Varthalitis, J.
    Ardavanis, A.
    Christopoulou, A.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [47] A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).
    Janne, PA
    Obasaju, C
    Simon, G
    Taub, R
    Kelly, K
    Fidias, P
    Bloss, LP
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 629S - 629S
  • [48] Phase II clinical trial of kahalalide F (KF) as a second line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Provencio, Mariano
    Izquierdo, Angel
    Vinolas, Nuria
    Paz-Ares, Luis
    Feliu, Jaime
    Constenla, Manuel
    de las Heras, Begona
    Erustes, Mercedes
    Izquierdo, Miguel A.
    Rosell, Rafael
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [49] Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study
    Kortsik, C
    Albrecht, P
    Elmer, A
    LUNG CANCER, 2003, 40 (01) : 85 - 90
  • [50] Chemotherapy with gemcitabine plus cisplatin in the treatment of locally advanced non-small cell lung cancer (NSCLC): a Brazilian study of 84 patients
    Ismael, Gustavo V.
    Beato, Carlos A.
    Coradazzi, Ana Lucia
    Budin, Jose Valfredo
    Moraes Neto, Francisco A.
    Nunes, Adauto J.
    Segaila, Jose Getulio M.
    ANNALS OF ONCOLOGY, 2004, 15 : 175 - 175
12345